Introduction to a review series on Hodgkin lymphoma: change is here.

Laurie H. Sehn, MDCM, MPH, shares highlights of this review series. Hodgkin lymphoma (HL) represents one of the earliest success stories of medical oncology. Following the initial demonstration that radiation therapy could eradicate early-stage disease, multiagent chemotherapy regimens were